Tagged with S

Sweden Though far from the largest pharma market in Europe, Sweden nevertheless holds strategic importance for global pharma; from the country’s attitude to public health to its sophisticated digital framework, comprehensive patient registries and innovative spirit. Here, four pharma country managers hailing from outside Sweden’s borders give their first impressions of…

Opinion Vishal Doshi looks at how AI is already revolutionising healthcare in Asia-Pacific and the work still to be done on the foundational elements – infrastructure, regulations, and the availability of Asia-specific data – to ensure AI can be effectively utilised to improve patient outcomes in the region.   Healthcare, manufacturing,…

China Japanese ophthalmology specialist Santen first established a China affiliate in 2005 and has grown very successfully in the past 14 years. GM of Santen Pharmaceutical (China) Co., Ltd. (hereafter, Santen China) Takayuki Yamada gives his first impressions of the Chinese market since his arrival in April 2019, Santen’s commitment to…

Taiwan Dr Huey-Jen Jenny Su, president of National Cheng Kung University, elaborates on her ambitions to reclaim the institution’s unique historical positioning as Taiwan’s most impactful university. She goes on to highlight NCKU’s capacity to nurture interdisciplinary projects, which through the university’s strong academia-industry collaboration, have achieved concrete societal benefits. She…

Sweden Ascelia Pharma is a Swedish oncology start-up based in Malmö. CEO Magnus Corfitzen talks about the opportunities they have found in the orphan oncology drug market, the promising phase III study for their lead asset, Mangoral, and his journey navigating the Swedish life science industry.   With Mangoral, we are…

Taiwan Tessie Che, chairperson & GM of Amaran Biotech shares the story of how she came to lead the company and set its course to become a leading specialty biopharma CMO that leverages high-quality products and best manufacturing practices above all else. As a veteran in the life sciences and pharma…

Puerto Rico CRB is a global consulting, design and construction services firm specialized in the life sciences industry. Tom Forester, general manager of CRB Caribe, based in Puerto Rico, shares the developments of the company in the past few years, what makes CRB the partner of choice for life sciences companies and…

Taiwan Ying-Yao Cheng, president of National Sun Yat-sen University, highlights the institution’s specialized expertise in marine sciences and goes on to elaborate on the important role of NSYSU in developing talent, translational research, and innovation both domestically and internationally. Cheng also describes the university’s capabilities in cross-disciplinary research projects, particularly in…

China China’s pharma market is growing at an unprecedented pace and has become a key element of virtually all pharma multinationals’ international strategies. However, with a spate of regulatory reforms being rolled out, it can be challenging for large organizations with headquarters located in slower-paced mature markets to adapt to China’s…

USA Although Boston and California may be more internationally renowned as biotech hubs, New York is fast catching up. Thanks in large part to its strong scientific and business infrastructure and easy access to capital, growing numbers of early-stage biotechs are choosing to base their operations in New York and list…

France France – one of the most influential countries in the development of gene therapy– still stands as a global powerhouse in the field, with top-class institutions, a dense network of expertise and increasing political support. However, financing and manufacturing French gene therapies is proving an issue, meaning that France is…

France With a feel-good factor sweeping French innovative pharma, the country’s iconic mid-cap biopharma standard-bearers are once more on the rise. These medium-sized national champions form part of G5 Santé, a club of companies altogether contributing some EUR 4.5 billion (USD 5 billion) worth of turnover to the home market and…